Closing remarks and shareholder vote

The 2019 AGM approved the remuneration policy for the Supervisory Board of Koninklijke DSM N.V. (98.45% in favor) as well as the remuneration policy for the Managing Board of Koninklijke DSM N.V. (97.48% in favor). The total remuneration delivered in 2021 is aligned with the respective remuneration policies: no deviations or derogations applied. As in 2020, no revision or claw-back of any incentives occurred in 2021.

The remuneration for the financial year 2021, as described in this report, is subject to an advisory vote at the 2022 AGM. Questions raised in the 2021 AGM regarding remuneration items were addressed in the respective meeting (reference is made to the Q&A document and minutes of that meeting, posted on the company website). As a result, there were no specifics raised that needed to be addressed in this Remuneration report.

Heerlen, 1 March 2022

The Supervisory Board
Thomas Leysen, Chair
John Ramsay, Deputy Chair
Eileen Kennedy
Carla Mahieu
Erica Mann
Frits van Paasschen
Pradeep Pant
Corien Wortmann-Kool